Navigation Links
China Contract Research Organization (CRO) Industry Report, 2010-2011
Date:8/18/2011

NEW YORK, Aug. 18, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Contract Research Organization (CRO) Industry Report, 2010-2011

http://www.reportlinker.com/p0590608/China-Contract-Research-Organization-CRO-Industry-Report-2010-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc

Under the circumstances of increasingly high R&D costs of new drugs worldwide, the contract research organization (CRO) industry has developed rapidly in recent years thanks to its advantages of shortening the R&D cycle and cost saving. In 2010, the global market size of CRO achieved RMB36 billion, which undertook nearly one third of the R&D of new drugs. CRO industry started relatively late in China, and still in its initial stage with only a few business varieties. In China, the market size of CRO was merely USD2.6 billion (about RMB16.9 billion) in 2010. However, with rapid development, currently there are almost 500 CRO enterprises in China.

Although there are many CRO enterprises in China, large-scale enterprises are less than 10 companies. WuXi AppTec and ShangPharma, two NYSE listed companies, are the largest CRO enterprises in China. WuXi AppTec is the leading enterprise in domestic CRO industry, whose clients include 9 of the top 10 pharmaceutical enterprises worldwide. In Jan. 2008, it successfully acquired AppTec Laboratory Services Inc. for USD151 million, initiating the overseas expansion of Chinese CRO enterprises.

ShangPharma is the second largest CRO enterprise in China. It has over 100 enterprise and academic research institution clients, including the top 10 pharmaceutical enterprises in the world. With the aim to enhance its R&D strength, ShangPharma plans to construct cGMP base and laboratory service building with the funds raised from its IPO in 2010.

Currently, most of the CRO enterprises can only accomplish a single section in the R&D process, therefore, in order to complete the industry chain and enhance the competitiveness, M&A and setting up industry alliance has become a trend in China's CRO industry. From 2007 to Apr. 2011, there were at least 6 M&A cases in the CRO industry of China. As of Apr. 2011, there were five biopharmaceutical CRO industry alliances in China, including Alliance of Bio-Box Outsourcing, China, Zhongguancun Bio-pharmaceutical R&D Outsourcing Alliance, Shanghai Pudong Bio-Pharmaceutical R&D Outsourcing Service Alliance, CROSA and Chengdu Bio-pharmaceutical R&D Outsourcing Alliance. Having witnessed the advantage of CRO alliances in China, foreign companies participated in as well. For instance, the European company NovaSecta joined CROSA.

Table of Contents1. Overview of CRO Industry

1.1 Definition & Classification

1.2 Industry Background

2. Development Environment of CRO Industry in China

2.1 International Environment

2.2 Industry Environment

2.3 Policy Environment

3. Market Analysis of CRO Industry in China

3.1 Status Quo

3.2 Market Size

3.3 Competition Pattern

3.4 Prospects

3.4.1 Specialized Division of Labor

3.4.2 Low Entry Barriers

3.4.3 Huge Demand

3.5 CRO Industry Alliances in China

3.5.1 ABO

3.5.2 Zhongguancun Bio-pharmaceutical R&D Outsourcing Alliance

3.5.3 Shanghai Pudong Bio-Pharmaceutical R&D Outsourcing Service Alliance

3.5.4 CROSA

3.5.5 Chengdu Bio-pharmaceutical R&D Outsourcing Alliance

4. Regional Market

4.1 Beijing

4.1.1 Pharmaceutical Manufacturing with Steady Growth

4.1.2 G20 Enterprises have Become the Core Strength of Industrial Development

4.1.3 R&D Services Industry Presents Prominent Contribution, with ABO Union Becoming an Important Force.

4.2 Shanghai

4.2.1 State Biotech & Pharmaceutical Industrial Base (Shanghai) (Zhangjiang Drug Valley)

4.3 Nanjing

4.3.1 Market Advantage

4.3.2 Development Prospects

5. Key CRO Enterprises Worldwide

5.1 COVANCE

5.1.1 Profile

5.1.2 Operation

5.1.3 Business in China

5.2 PAREXEL INTERNATIONAL

5.2.1 Profile

5.2.2 Business in China

5.3 PPD

5.3.1 Profile

5.3.2 Business in China

5.4 Quintiles Transnational

5.4.1 Profile

5.4.2 Business in China

5.5 Charles River Labs (CRL)

5.5.1 Profile

5.5.2 Business in China

5.6 Asymchem Inc

5.6.1 Profile

5.6.2 Asymchem Laboratories (Tianjin) Co. Ltd.

5.6.3 Asymchem Life Science (Tianjin) Co., Ltd.

5.7 MDS Inc.

5.7.1 Profile

5.7.2 MDS Pharma Services (China) Inc.

6. Key CRO Enterprises in China

6.1 WuXi AppTec Co., Ltd.

6.1.1 Profile

6.1.2 Operation

6.1.3 Business Structure

6.1.4 Development

6.2 ShangPharma Corp

6.2.1 Profile

6.2.2 Operation

6.2.3 Development

6.2.4 Shanghai ChemPartner Co. Ltd

6.2.5 Shanghai ChemExplorer Co. Ltd

6.2.6 Chengdu China Gateway Pharmaceutical Development Co. Ltd

6.3 Venturepharm Laboratories Limited

6.3.1 Profile

6.3.2 Operation

6.3.3 Development

6.4 Sundia MediTech Co., Ltd

6.5 Chemizon (Beijing) Pharma-Tech Co., Ltd

6.6 Excel PharmaStudies Co. Ltd

6.7 Tigermed Pharma-Tech Co., Ltd

Selected ChartsClassification of CRO

Market Size and Growth Rate of Global CRO, 2007-2010

Global Key CRO Organizations and Their Business

Industrial Sales Output Value and Growth Rate of Pharmaceutical Manufacturing Industry in China, 2008-Apr. 2011

Output Value of New Products of Pharmaceutical Manufacturing Industry in China, 2008-2010

Classification of Chinese CRO Companies (by Business)

Market Size and Growth Rate of CRO in China, 2007-2010

Key M&A Cases of CRO Industry in China, 2007-2011

Orders and Revenue of ABO Union and Proportions in International Orders ,2008-2010

Key Members and Unique Services of ABO Union

Sponsor of Zhongguancun CRO Union (in no particular order)

Biopharmaceutical CRO Companies in Shanghai Pudong New Area

CRO Service Chain of Shanghai Pudong Zhangjiang

Operating Income and Total Profit of Beijing Pharmaceutical Industry by Sector, 2010

Advantageous Fields of Beijing CRO Services

Platform Edge of Zhangjiang Drug Valley

List of Major CRO Companies of Zhangjiang Drug Valley, Shanghai

Industry Advantages of CRO Nanjing

Operating Income and Gross Margin of Covance, 2007-2010

Operating Income of Covance (by Business), 2008-2010

Operating Income of PAREXEL, 2007-2010

Revenue of PAREXEL Worldwide (by Region), 2008-2010

Operating Income of PPD, 2007-2010

Sales of CRL, 2007-2010

Companies of Asymchem Inc in China and Major Business

Operation of Asymchem Laboratories (Tianjin), 2008 and Jan. 2009- May 2009

Operation of Asymchem Life Science (Tianjin), 2008

Major Facilities of WuXi AppTec

Sales and Gross Margin of WuXi AppTec, 2008-2010

Sales of WuXi AppTec (By Business), 2010

Main Bases of ShangPharma Corp

Net Income and Gross Profit of ShangPharma Corp, 2008-2010

Net Income of ShangPharma Corp Worldwide (by Region), 2007-2009

Revenue and Gross Profit of Venturepharm Laboratories Limited, 2007- Jan.- Mar.2011

Operation of Venturepharm Laboratories Limited, 2007-Jan.- Mar.2011

Patents Applied by Venturepharm Laboratories Limited

Strength of Excel PharmaStudies

Main Clients of Tigermed Pharma-Tech

To order this report:Drug Discovery and Development Industry: China Contract Research Organization (CRO) Industry Report, 2010-2011

Drug Discovery and Development Business News

More  Company Profile, SWOT and Revenue Analysis!CONTACT:  Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
2. China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.s Sales Forecast in Excess of $10,000,000
3. China Medical Technologies Reports First Fiscal Quarter Financial Results
4. Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
5. Concord Medical and GE Healthcare Sign MOU for Preferred Partnership in China
6. China Nuvo Solar Target Acquisition SurgLine Announces Agreement With Western U.S. Distributor
7. China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results
8. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
9. China Medical Technologies Announces the First Inclusion of FISH Tests for Diagnosis of Certain Hematological Malignancies in the Clinical Guidelines Issued by the MOH
10. China Sky One Medical Announces Second Quarter 2011 Results
11. China Medical Technologies and Leica Microsystems Announce Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):